Abbott Diagnostic Products — Goodwill, non-deductible increased by 313.9% to $14.90B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 325.7%, from $3.50B to $14.90B. Over 3 years (FY 2022 to FY 2025), Diagnostic Products — Goodwill, non-deductible shows relatively stable performance with a -0.2% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
High levels may indicate past aggressive acquisition strategies, while changes reflect impairment testing or new M&A activity.
The portion of goodwill arising from acquisitions within the diagnostics segment that cannot be deducted for tax purpose...
Standard accounting metric for companies with significant M&A history.
abt_segment_diagnostic_products_goodwill_non_deductible| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | 3.8B | 3.8B | 3.7B | 3.7B | 3.6B | 3.5B | 3.6B | 3.5B | 3.5B | 3.5B | 3.6B | 3.5B | 3.5B | 3.6B | 3.5B | 3.5B | 3.6B | 3.6B | 3.6B | 14.9B |
| QoQ Change | — | +0.0% | -2.6% | +0.0% | -2.7% | -2.8% | +2.9% | -2.8% | +0.0% | +0.0% | +2.9% | -2.8% | +0.0% | +2.9% | -2.8% | +0.0% | +2.9% | +0.0% | +0.0% | +313.9% |
| YoY Change | — | — | — | — | -5.3% | -7.9% | -2.7% | -5.4% | -2.8% | +0.0% | +0.0% | +0.0% | +0.0% | +2.9% | -2.8% | +0.0% | +2.9% | +0.0% | +2.9% | +325.7% |